{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:12:36Z","timestamp":1788246756366,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T00:00:00Z","timestamp":1404432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T00:00:00Z","timestamp":1404432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/scrt472","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T09:03:53Z","timestamp":1404464633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Mesenchymal stem cell treatment for chronic renal failure"],"prefix":"10.1186","volume":"5","author":[{"given":"Alfonso","family":"Eirin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilach O","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,4]]},"reference":[{"key":"370_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW: Chronic kidney disease: global dimension and perspectives. Lancet. 2013, 382: 260-272. 10.1016\/S0140-6736(13)60687-X.","journal-title":"Lancet"},{"key":"370_CR2","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1681\/ASN.2005010112","volume":"16","author":"DT Gilbertson","year":"2005","unstructured":"Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, Collins AJ: Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005, 16: 3736-3741. 10.1681\/ASN.2005010112.","journal-title":"J Am Soc Nephrol"},{"key":"370_CR3","doi-asserted-by":"publisher","first-page":"e1001307","DOI":"10.1371\/journal.pmed.1001307","volume":"9","author":"M Wyld","year":"2012","unstructured":"Wyld M, Morton RL, Hayen A, Howard K, Webster AC: A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012, 9: e1001307-10.1371\/journal.pmed.1001307.","journal-title":"PLoS Med"},{"key":"370_CR4","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2011.11.015","volume":"59","author":"AJ Collins","year":"2012","unstructured":"Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J: United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012, 59: A7-e1-e420","journal-title":"Am J Kidney Dis"},{"key":"370_CR5","doi-asserted-by":"crossref","first-page":"iii19","DOI":"10.1093\/ndt\/gfs284","volume":"27","author":"N Perico","year":"2012","unstructured":"Perico N, Remuzzi G: Chronic kidney disease: a research and public health priority. Nephrol Dial Transplant. 2012, 27: iii19-iii26.","journal-title":"Nephrol Dial Transplant"},{"key":"370_CR6","first-page":"749","volume":"86","author":"JA Rivera","year":"2012","unstructured":"Rivera JA, O'Hare AM, Harper GM: Update on the management of chronic kidney disease. Am Fam Physician. 2012, 86: 749-754.","journal-title":"Am Fam Physician"},{"key":"370_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2169\/internalmedicine.43.9","volume":"43","author":"M Nangaku","year":"2004","unstructured":"Nangaku M: Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med. 2004, 43: 9-17. 10.2169\/internalmedicine.43.9.","journal-title":"Intern Med"},{"key":"370_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000346569","volume":"122","author":"T Kaneko","year":"2012","unstructured":"Kaneko T, Shimizu A, Mii A, Fujita E, Fujino T, Kunugi S, Du X, Akimoto T, Tsuruoka S, Ohashi R, Masuda Y, Iino Y, Katayama Y, Fukuda Y: Role of matrix metalloproteinase-2 in recovery after tubular damage in acute kidney injury in mice. Nephron Exp Nephrol. 2012, 122: 23-35. 10.1159\/000346569.","journal-title":"Nephron Exp Nephrol"},{"key":"370_CR9","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/S0140-6736(10)60237-1","volume":"375","author":"A Benigni","year":"2010","unstructured":"Benigni A, Morigi M, Remuzzi G: Kidney regeneration. Lancet. 2010, 375: 1310-1317. 10.1016\/S0140-6736(10)60237-1.","journal-title":"Lancet"},{"key":"370_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006, 8: 315-317. 10.1080\/14653240600855905.","journal-title":"Cytotherapy"},{"key":"370_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbmt.2008.01.006","volume":"14","author":"FE Ezquer","year":"2008","unstructured":"Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yanez AJ, Conget PA: Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant. 2008, 14: 631-640. 10.1016\/j.bbmt.2008.01.006.","journal-title":"Biol Blood Marrow Transplant"},{"key":"370_CR12","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","volume":"103","author":"RH Lee","year":"2006","unstructured":"Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, Prockop DJ: Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice. Proc Natl Acad Sci U S A. 2006, 103: 17438-17443. 10.1073\/pnas.0608249103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"370_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/scd.2008.0097","volume":"18","author":"S Choi","year":"2009","unstructured":"Choi S, Park M, Kim J, Hwang S, Park S, Lee Y: The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 2009, 18: 521-529. 10.1089\/scd.2008.0097.","journal-title":"Stem Cells Dev"},{"key":"370_CR14","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1089\/scd.2012.0096","volume":"21","author":"M Franquesa","year":"2012","unstructured":"Franquesa M, Herrero E, Torras J, Ripoll E, Flaquer M, Goma M, Lloberas N, Anegon I, Cruzado JM, Grinyo JM, Herrero-Fresneda I: Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model. Stem Cells Dev. 2012, 21: 3125-3135. 10.1089\/scd.2012.0096.","journal-title":"Stem Cells Dev"},{"key":"370_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/stem.1263","volume":"31","author":"XY Zhu","year":"2013","unstructured":"Zhu XY, Urbieta-Caceres V, Krier JD, Textor SC, Lerman A, Lerman LO: Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. Stem Cells. 2013, 31: 117-125. 10.1002\/stem.1263.","journal-title":"Stem Cells"},{"key":"370_CR16","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/stem.1047","volume":"30","author":"A Eirin","year":"2012","unstructured":"Eirin A, Zhu XY, Krier JD, Tang H, Jordan KL, Grande JP, Lerman A, Textor SC, Lerman LO: Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells. 2012, 30: 1030-1041. 10.1002\/stem.1047.","journal-title":"Stem Cells"},{"key":"370_CR17","doi-asserted-by":"publisher","first-page":"e67474","DOI":"10.1371\/journal.pone.0067474","volume":"8","author":"B Ebrahimi","year":"2013","unstructured":"Ebrahimi B, Eirin A, Li Z, Zhu XY, Zhang X, Lerman A, Textor SC, Lerman LO: Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis. PLoS One. 2013, 8: e67474-10.1371\/journal.pone.0067474.","journal-title":"PLoS One"},{"key":"370_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS: Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009, 18: 683-692. 10.1089\/scd.2008.0253.","journal-title":"Stem Cells Dev"},{"key":"370_CR19","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1182\/blood-2002-06-1830","volume":"101","author":"SM Devine","year":"2003","unstructured":"Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R: Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003, 101: 2999-3001. 10.1182\/blood-2002-06-1830.","journal-title":"Blood"},{"key":"370_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mvr.2009.02.001","volume":"77","author":"D Furlani","year":"2009","unstructured":"Furlani D, Ugurlucan M, Ong L, Bieback K, Pittermann E, Westien I, Wang W, Yerebakan C, Li W, Gaebel R, Li RK, Vollmar B, Steinhoff G, Ma N: Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009, 77: 370-376. 10.1016\/j.mvr.2009.02.001.","journal-title":"Microvasc Res"},{"key":"370_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.transproceed.2009.01.072","volume":"41","author":"RC Cavaglieri","year":"2009","unstructured":"Cavaglieri RC, Martini D, Sogayar MC, Noronha IL: Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant Proc. 2009, 41: 947-951. 10.1016\/j.transproceed.2009.01.072.","journal-title":"Transplant Proc"},{"key":"370_CR22","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.3727\/096368912X640448","volume":"21","author":"C Alfarano","year":"2012","unstructured":"Alfarano C, Roubeix C, Chaaya R, Ceccaldi C, Calise D, Mias C, Cussac D, Bascands JL, Parini A: Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Cell Transplant. 2012, 21: 2009-2019. 10.3727\/096368912X640448.","journal-title":"Cell Transplant"},{"key":"370_CR23","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/stem.426","volume":"28","author":"AR Chade","year":"2010","unstructured":"Chade AR, Zhu XY, Krier JD, Jordan KL, Textor SC, Grande JP, Lerman A, Lerman LO: Endothelial progenitor cells homing and renal repair in experimental renovascular disease. Stem Cells. 2010, 28: 1039-1047. 10.1002\/stem.426.","journal-title":"Stem Cells"},{"key":"370_CR24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/sj.ki.5002334","volume":"72","author":"MB Herrera","year":"2007","unstructured":"Herrera MB, Bussolati B, Bruno S, Morando L, Mauriello-Romanazzi G, Sanavio F, Stamenkovic I, Biancone L, Camussi G: Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007, 72: 430-441. 10.1038\/sj.ki.5002334.","journal-title":"Kidney Int"},{"key":"370_CR25","doi-asserted-by":"publisher","first-page":"e34608","DOI":"10.1371\/journal.pone.0034608","volume":"7","author":"H Liu","year":"2012","unstructured":"Liu H, Liu S, Li Y, Wang X, Xue W, Ge G, Luo X: The role of SDF-1-CXCR4\/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia\/reperfusion injury. PLoS One. 2012, 7: e34608-10.1371\/journal.pone.0034608.","journal-title":"PLoS One"},{"key":"370_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/hum.2008.016","volume":"19","author":"M Hagiwara","year":"2008","unstructured":"Hagiwara M, Shen B, Chao L, Chao J: Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther. 2008, 19: 807-819. 10.1089\/hum.2008.016.","journal-title":"Hum Gene Ther"},{"key":"370_CR27","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1634\/stemcells.2007-1000","volume":"26","author":"C Mias","year":"2008","unstructured":"Mias C, Trouche E, Seguelas MH, Calcagno F, Dignat-George F, Sabatier F, Piercecchi-Marti MD, Daniel L, Bianchi P, Calise D, Bourin P, Parini A, Cussac D: Ex vivo pretreatment with melatonin improves survival, proangiogenic\/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells. 2008, 26: 1749-1757. 10.1634\/stemcells.2007-1000.","journal-title":"Stem Cells"},{"key":"370_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3727\/096368912X653246","volume":"22","author":"C Xinaris","year":"2013","unstructured":"Xinaris C, Morigi M, Benedetti V, Imberti B, Fabricio AS, Squarcina E, Benigni A, Gagliardini E, Remuzzi G: A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. Cell Transplant. 2013, 22: 423-436. 10.3727\/096368912X653246.","journal-title":"Cell Transplant"},{"key":"370_CR29","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1681\/ASN.2005101043","volume":"17","author":"T Yokoo","year":"2006","unstructured":"Yokoo T, Fukui A, Ohashi T, Miyazaki Y, Utsunomiya Y, Kawamura T, Hosoya T, Okabe M, Kobayashi E: Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J Am Soc Nephrol. 2006, 17: 1026-1034. 10.1681\/ASN.2005101043.","journal-title":"J Am Soc Nephrol"},{"key":"370_CR30","first-page":"1035","volume":"14","author":"MB Herrera","year":"2004","unstructured":"Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G: Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004, 14: 1035-1041.","journal-title":"Int J Mol Med"},{"key":"370_CR31","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/01.ASN.0000128974.07460.34","volume":"15","author":"M Morigi","year":"2004","unstructured":"Morigi M, Imberti B, Zoja C, Corna D, Tomasoni S, Abbate M, Rottoli D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi G: Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004, 15: 1794-1804. 10.1097\/01.ASN.0000128974.07460.34.","journal-title":"J Am Soc Nephrol"},{"key":"370_CR32","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1681\/ASN.2007020140","volume":"18","author":"B Bi","year":"2007","unstructured":"Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG: Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol. 2007, 18: 2486-2496. 10.1681\/ASN.2007020140.","journal-title":"J Am Soc Nephrol"},{"key":"370_CR33","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","volume":"289","author":"F Togel","year":"2005","unstructured":"Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005, 289: F31-F42. 10.1152\/ajprenal.00007.2005.","journal-title":"Am J Physiol Renal Physiol"},{"key":"370_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/1479-5876-10-243","volume":"10","author":"MS Masoud","year":"2012","unstructured":"Masoud MS, Anwar SS, Afzal MZ, Mehmood A, Khan SN, Riazuddin S: Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftment. J Transl Med. 2012, 10: 243-10.1186\/1479-5876-10-243.","journal-title":"J Transl Med"},{"key":"370_CR35","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1681\/ASN.2005080815","volume":"17","author":"U Kunter","year":"2006","unstructured":"Kunter U, Rong S, Djuric Z, Boor P, Muller-Newen G, Yu D, Floege J: Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol. 2006, 17: 2202-2212. 10.1681\/ASN.2005080815.","journal-title":"J Am Soc Nephrol"},{"key":"370_CR36","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1681\/ASN.2006121318","volume":"18","author":"B Imberti","year":"2007","unstructured":"Imberti B, Morigi M, Tomasoni S, Rota C, Corna D, Longaretti L, Rottoli D, Valsecchi F, Benigni A, Wang J, Abbate M, Zoja C, Remuzzi G: Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol. 2007, 18: 2921-2928. 10.1681\/ASN.2006121318.","journal-title":"J Am Soc Nephrol"},{"key":"370_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/ndt\/gft305","volume":"29","author":"A Eirin","year":"2014","unstructured":"Eirin A, Zhang X, Zhu XY, Tang H, Jordan KL, Grande JP, Dietz AB, Lerman A, Textor SC, Lerman LO: Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis. Nephrol Dial Transplant. 2014, 29: 274-282. 10.1093\/ndt\/gft305.","journal-title":"Nephrol Dial Transplant"},{"key":"370_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.exphem.2004.02.004","volume":"32","author":"EH Javazon","year":"2004","unstructured":"Javazon EH, Beggs KJ, Flake AW: Mesenchymal stem cells: paradoxes of passaging. Exp Hematol. 2004, 32: 414-425. 10.1016\/j.exphem.2004.02.004.","journal-title":"Exp Hematol"},{"key":"370_CR39","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1161\/CIRCULATIONAHA.110.955971","volume":"122","author":"XP Huang","year":"2010","unstructured":"Huang XP, Sun Z, Miyagi Y, McDonald Kinkaid H, Zhang L, Weisel RD, Li RK: Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation. 2010, 122: 2419-2429. 10.1161\/CIRCULATIONAHA.110.955971.","journal-title":"Circulation"},{"key":"370_CR40","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","volume":"106","author":"N Eliopoulos","year":"2005","unstructured":"Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J: Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood. 2005, 106: 4057-4065. 10.1182\/blood-2005-03-1004.","journal-title":"Blood"},{"key":"370_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.lfs.2010.10.023","volume":"88","author":"KM Peterson","year":"2011","unstructured":"Peterson KM, Aly A, Lerman A, Lerman LO, Rodriguez-Porcel M: Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress. Life Sci. 2011, 88: 65-73. 10.1016\/j.lfs.2010.10.023.","journal-title":"Life Sci"},{"key":"370_CR42","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1681\/ASN.2007010044","volume":"18","author":"U Kunter","year":"2007","unstructured":"Kunter U, Rong S, Boor P, Eitner F, Muller-Newen G, Djuric Z, van Roeyen CR, Konieczny A, Ostendorf T, Villa L, Milovanceva-Popovska M, Kerjaschki D, Floege J: Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol. 2007, 18: 1754-1764. 10.1681\/ASN.2007010044.","journal-title":"J Am Soc Nephrol"},{"key":"370_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","volume":"25","author":"J Tolar","year":"2007","unstructured":"Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, Hirsch B, Yant SR, Kay MA, Peister A, Prockop DJ, Fibbe WE, Blazar BR: Sarcoma derived from cultured mesenchymal stem cells. Stem Cells. 2007, 25: 371-379. 10.1634\/stemcells.2005-0620.","journal-title":"Stem Cells"},{"key":"370_CR44","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1681\/ASN.2009111156","volume":"21","author":"D Thirabanjasak","year":"2010","unstructured":"Thirabanjasak D, Tantiwongse K, Thorner PS: Angiomyeloproliferative lesions following autologous stem cell therapy. J Am Soc Nephrol. 2010, 21: 1218-1222. 10.1681\/ASN.2009111156.","journal-title":"J Am Soc Nephrol"},{"key":"370_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/ATVBAHA.113.301164","volume":"33","author":"A Eirin","year":"2013","unstructured":"Eirin A, Zhu XY, Li Z, Ebrahimi B, Zhang X, Tang H, Korsmo MJ, Chade AR, Grande JP, Ward CJ, Simari RD, Lerman A, Textor SC, Lerman LO: Endothelial outgrowth cells shift macrophage phenotype and improve kidney viability in swine renal artery stenosis. Arterioscler Thromb Vasc Biol. 2013, 33: 1006-1013. 10.1161\/ATVBAHA.113.301164.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"370_CR46","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.addr.2012.07.001","volume":"65","author":"RW Yeo","year":"2013","unstructured":"Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, Lim SK: Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev. 2013, 65: 336-341. 10.1016\/j.addr.2012.07.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"370_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2217\/rme.11.35","volume":"6","author":"RC Lai","year":"2011","unstructured":"Lai RC, Chen TS, Lim SK: Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 2011, 6: 481-492. 10.2217\/rme.11.35.","journal-title":"Regen Med"},{"key":"370_CR48","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1089\/scd.2012.0095","volume":"21","author":"HC Zhang","year":"2012","unstructured":"Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, Wang YQ, Cao XF, Lv J, Xiao FJ, Yang Y, Guo ZK: Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev. 2012, 21: 3289-3297. 10.1089\/scd.2012.0095.","journal-title":"Stem Cells Dev"},{"key":"370_CR49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/ndt\/gfr267","volume":"27","author":"H Noh","year":"2012","unstructured":"Noh H, Yu MR, Kim HJ, Jeon JS, Kwon SH, Jin SY, Lee J, Jang J, Park JO, Ziyadeh F, Han DC, Lee HB: Uremia induces functional incompetence of bone marrow-derived stromal cells. Nephrol Dial Transplant. 2012, 27: 218-225. 10.1093\/ndt\/gfr267.","journal-title":"Nephrol Dial Transplant"},{"key":"370_CR50","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/ki.2012.187","volume":"82","author":"M Roemeling-van Rhijn","year":"2012","unstructured":"Roemeling-van Rhijn M, Reinders ME, de Klein A, Douben H, Korevaar SS, Mensah FK, Dor FJ, Ijzermans NJ, Betjes MG, Baan CC, Weimar W, Hoogduijn MJ: Mesenchymal stem cells derived from adipose tissue are not affected by renal disease. Kidney Int. 2012, 82: 748-758. 10.1038\/ki.2012.187.","journal-title":"Kidney Int"},{"key":"370_CR51","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ: Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012, 7: e47559-10.1371\/journal.pone.0047559.","journal-title":"PLoS One"},{"key":"370_CR52","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V: Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008, 8: 726-736. 10.1038\/nri2395.","journal-title":"Nat Rev Immunol"},{"key":"370_CR53","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/stem.118","volume":"27","author":"G Ren","year":"2009","unstructured":"Ren G, Su J, Zhang L, Zhao X, Ling W, L'Huillie A, Zhang J, Lu Y, Roberts AI, Ji W, Zhang H, Rabson AB, Shi Y: Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells. 2009, 27: 1954-1962. 10.1002\/stem.118.","journal-title":"Stem Cells"},{"key":"370_CR54","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3109\/14653249.2011.651529","volume":"14","author":"G Kumar","year":"2012","unstructured":"Kumar G, Hara H, Long C, Shaikh H, Ayares D, Cooper DK, Ezzelarab M: Adipose-derived mesenchymal stromal cells from genetically modified pigs: immunogenicity and immune modulatory properties. Cytotherapy. 2012, 14: 494-504. 10.3109\/14653249.2011.651529.","journal-title":"Cytotherapy"},{"key":"370_CR55","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0166-2236(89)90040-4","volume":"12","author":"MG Honig","year":"1989","unstructured":"Honig MG, Hume RI: Dil and diO: versatile fluorescent dyes for neuronal labelling and pathway tracing. Trends Neurosci. 1989, 12: 333-335. 10.1016\/0166-2236(89)90040-4. 340\u2013341","journal-title":"Trends Neurosci"},{"key":"370_CR56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1432-0436.2006.00149.x","volume":"75","author":"SJ Bruce","year":"2007","unstructured":"Bruce SJ, Rea RW, Steptoe AL, Busslinger M, Bertram JF, Perkins AC: In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation. 2007, 75: 337-349. 10.1111\/j.1432-0436.2006.00149.x.","journal-title":"Differentiation"},{"key":"370_CR57","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/0006-2952(95)00060-D","volume":"49","author":"WM Anderson","year":"1995","unstructured":"Anderson WM, Trgovcich-Zacok D: Carbocyanine dyes with long alkyl side-chains: broad spectrum inhibitors of mitochondrial electron transport chain activity. Biochem Pharmacol. 1995, 49: 1303-1311. 10.1016\/0006-2952(95)00060-D.","journal-title":"Biochem Pharmacol"},{"key":"370_CR58","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-3148.2003.00463.x","volume":"13","author":"CM Rice","year":"2003","unstructured":"Rice CM, Halfpenny CA, Scolding NJ: Stem cells for the treatment of neurological disease. Transfus Med. 2003, 13: 351-361. 10.1111\/j.1365-3148.2003.00463.x.","journal-title":"Transfus Med"},{"key":"370_CR59","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1101\/gad.1047403","volume":"17","author":"TF Massoud","year":"2003","unstructured":"Massoud TF, Gambhir SS: Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003, 17: 545-580. 10.1101\/gad.1047403.","journal-title":"Genes Dev"},{"key":"370_CR60","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.105.537480","volume":"112","author":"DL Kraitchman","year":"2005","unstructured":"Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, Segars WP, Chen HH, Fritzges D, Izbudak I, Young RG, Marcelino M, Pittenger MF, Solaiyappan M, Boston RC, Tsui BM, Wahl RL, Bulte JW: Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation. 2005, 112: 1451-1461. 10.1161\/CIRCULATIONAHA.105.537480.","journal-title":"Circulation"},{"key":"370_CR61","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3348\/kjr.2009.10.3.277","volume":"10","author":"SI Jung","year":"2009","unstructured":"Jung SI, Kim SH, Kim HC, Son KR, Chung SY, Moon WK, Kim HS, Choi JS, Moon MH, Sung CK: In vivo MR imaging of magnetically labeled mesenchymal stem cells in a rat model of renal ischemia. Korean J Radiol. 2009, 10: 277-284. 10.3348\/kjr.2009.10.3.277.","journal-title":"Korean J Radiol"},{"key":"370_CR62","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/jmri.20925","volume":"25","author":"H Ittrich","year":"2007","unstructured":"Ittrich H, Lange C, Togel F, Zander AR, Dahnke H, Westenfelder C, Adam G, Nolte-Ernsting C: In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3\u00a0T. J Magn Reson Imaging. 2007, 25: 1179-1191. 10.1002\/jmri.20925.","journal-title":"J Magn Reson Imaging"},{"key":"370_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5966\/sctm.2012-0114","volume":"2","author":"ME Reinders","year":"2013","unstructured":"Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, Claas FH, van Miert PP, Roelen DL, van Kooten C, Fibbe WE, Rabelink TJ: Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med. 2013, 2: 107-111. 10.5966\/sctm.2012-0114.","journal-title":"Stem Cells Transl Med"},{"key":"370_CR64","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","volume":"307","author":"J Tan","year":"2012","unstructured":"Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J, Gao X, Pileggi A, Ricordi C: Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA. 2012, 307: 1169-1177. 10.1001\/jama.2012.316.","journal-title":"JAMA"},{"key":"370_CR65","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2215\/CJN.04950610","volume":"6","author":"N Perico","year":"2011","unstructured":"Perico N, Casiraghi F, Introna M, Gotti E, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Maras\u00e0 M, Golay J, Noris M, Remuzzi G: Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility. Clin J Am Soc Nephrol. 2011, 6: 412-422. 10.2215\/CJN.04950610.","journal-title":"Clin J Am Soc Nephrol"},{"key":"370_CR66","unstructured":"Clinicaltrials.gov.http:\/\/clinicaltrials.gov,"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/scrt472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/scrt472\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/scrt472.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:37:54Z","timestamp":1714063074000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/scrt472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,4]]},"references-count":66,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,12]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1186\/scrt472","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,4]]},"assertion":[{"value":"4 July 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"83"}}